-Sergei V Kotenko Researcher Activity Profile

Research Author Detailed Information 

Sergei V Kotenko Publication Rate By Year

Sergei V Kotenko has published 2 paper(s) in 2006, 6 paper(s) in 2007, 2 paper(s) in 2008, for a total of 10 research publications in total.

Sergei V Sv Kotenko Author Information

LAST NAME: kotenko

FIRST NAME: Sergei V

INITIALS: sv

AFFILIATION:

Papers

Sergei V Kotenko's Publication Record

1. Role of deficient type III interferon-lambda production in asthma exacerbations. Year Published: 2006
Department of Respiratory Medicine, National Heart and Lung Institute, Imperial College London, Norfolk Place, London W2 1PG, UK.
2. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Year Published: 2006
Center for the Study of Hepatitis C, The Rockefeller University, New York, New York 10021, USA.
3. Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential. Year Published: 2007
Department of Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ 07103, USA.
4. Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Year Published: 2007
Department of Biochemistry and Molecular Biology, University Hospital Cancer Center, New Jersey Medical School, Newark, NJ 07103, USA.
5. Adjunctive treatment of disseminated Mycobacterium avium complex infection with interferon alpha-2b in a patient with complete interferon-gamma receptor R1 deficiency. Year Published: 2007
Division of Pulmonology, Allergy/Immunology, and Infectious Diseases, Department of Pediatrics, New Jersey Medical School/UMDNJ, 185 South Orange Avenue, Newark, NJ 07101-1709, USA.
6. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. Year Published: 2007
Department of Viral Diseases and Immunology, National Public Health Institute, Helsinki, Finland. pamela.osterlund@ktl.fi
7. Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Year Published: 2007
Department of Biochemistry and Molecular Biology, University Hospital Cancer Center, New Jersey Medical School, Newark, NJ 07103, USA.
8. Down-Regulation of MHC II in Mesenchymal Stem Cells at High IFN-{gamma} Can Be Partly Explained by Cytoplasmic Retention of CIITA. Year Published: 2008
Graduate School of Biomedical Sciences, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103.
9. Adjunctive treatment of disseminated Mycobacterium avium complex infection with interferon alpha-2b in a patient with complete interferon-gamma receptor R1 deficiency. Year Published: 2007
Division of Pulmonology, Allergy/Immunology, and Infectious Diseases, Department of Pediatrics, New Jersey Medical School/UMDNJ, 185 South Orange Avenue, Newark, NJ 07101-1709, USA.
10. Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA. Year Published: 2008
Graduate School of Biomedical Sciences, University of Medicine and Dentistry of New Jersey, 185 South Orange Avenue, Newark, NJ 07103, USA.